Email not displaying correctly? View it in your browser.

Photo of Senator Terry Gerratana.


Terry Gerratana

Healthy Families, Healthy Communities

Creating Jobs and Expanding Bioscience with Smart State Investments

Last week, I cast my vote in favor of a bill that will improve Connecticut's ability to make targeted investments aimed at encouraging growth and job creation in bioscience and precision medicine. Senate Bill 962 calls for metrics to be developed by a private vendor that will help the state measure the impact of its investments. These metrics will be used by Connecticut Innovations to vet bioscience proposals. The bill receives unanimous, bipartisan support and now moves to the House of Representatives for further consideration.


A 2015 economic competitiveness diagnostic of Connecticut found that the state has great assets and economic drivers in research and development, bioscience and health data. In response to those findings, Senator Hartley and her colleagues on the legislature's Commerce Committee have worked with stakeholders to develop and pass legislation encouraging further development in these areas. As this industry grows, it is critical that the state know how to best target its financial support in order to ensure maximum job growth and economic impact. Once implemented, Senate Bill 962 will give the state a more accurate picture of industry trends, allowing the Department of Economic and Community Development and its other partners to better target state resources.